Home LiteratureArticle Details
PMID: 11480765 Published · ppublish English Journal Article Review

The 22q11.2 deletion syndrome.

Advances in pediatrics ·Vol. 48 ·2001-00-00 ·Pages 39-73

Emanuel BS, McDonald-McGinn D, Saitta SC, Zackai EH

Abstract

Estimates suggest that the 22q11.2 deletion occurs in approximately 1 in 4000 live births, making this disorder a significant health concern in the general population. The 22q11.2 deletion has been identified in the majority of patients with DiGeorge syndrome, velocardiofacial syndrome, and conotruncal anomaly face syndrome, suggesting that they are phenotypic variants of the same disorder. The findings associated with the 22q11.2 deletion are extensive and highly variable from patient to patient. In this chapter, we discuss the features of this disorder, with an emphasis on the clinical findings and an approach to the evaluation of these patients. In addition, we present the current understanding at the molecular level, of the genomic mechanisms and genes that are likely to play a central role in causing this frequent genetic condition.

MeSH Terms
Abnormalities, Multiple/genetics Adolescent Child Child, Preschool Chromosome Deletion Chromosomes, Human, Pair 22/genetics DiGeorge Syndrome/genetics Female Humans Infant Male Phenotype
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Emanuel B S
University of Pennsylvania School of Medicine, and The Children's Hospital of Philadelphia, USA.
McDonald-McGinn D
Saitta S C
Zackai E H
Article Info
Journal
Advances in pediatrics
Abbr.
Adv Pediatr
ISSN
0065-3101
Published
2001-00-00
Pages
39-73
Language
English
Region
United States
NLM ID
0370436
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com